Avidicure Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 35

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $48.5M

  • Investors
  • 7

Avidicure General Information

Description

Developer of a dual agonistic, multifunctional antibody modality designed to engage immune cells for targeted cancer treatment. The company offers avidity-engineered antibodies with localized activation in tumors, enabling oncology researchers to support immune responses while limiting off-target effects.

Contact Information

Website
www.avidicure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • De Limes 7
  • 2342 DH Oegstgeest
  • Netherlands
+31 071
Primary Industry
Drug Discovery
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • De Limes 7
  • 2342 DH Oegstgeest
  • Netherlands
+31 071

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avidicure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 24-Apr-2025 $48.5M Completed Stealth
1. Seed Round Completed Stealth
To view Avidicure’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Avidicure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avidicure Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioGeneration Ventures Venture Capital Minority
Brabantse Ontwikkelings Maatschappij Venture Capital Minority
Curie Capital Venture Capital Minority
EQT Life Sciences Venture Capital Minority
Kurma Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Avidicure FAQs

  • When was Avidicure founded?

    Avidicure was founded in 2022.

  • Where is Avidicure headquartered?

    Avidicure is headquartered in Oegstgeest, Netherlands.

  • What is the size of Avidicure?

    Avidicure has 35 total employees.

  • What industry is Avidicure in?

    Avidicure’s primary industry is Drug Discovery.

  • Is Avidicure a private or public company?

    Avidicure is a Private company.

  • What is Avidicure’s current revenue?

    The current revenue for Avidicure is .

  • How much funding has Avidicure raised over time?

    Avidicure has raised $48.5M.

  • Who are Avidicure’s investors?

    BioGeneration Ventures, Brabantse Ontwikkelings Maatschappij, Curie Capital, EQT Life Sciences, and Kurma Partners are 5 of 7 investors who have invested in Avidicure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process